Skip to content
Abierto
Menu

Award notice, first published as solicitation

FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan|

36C24826Q0337

Department of Veterans Affairs, 248-Network Contract Office 8. Medical Laboratories.

View on SAM.govMarkdown

Awarded

Interpace Diagnostics Corporation

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the presolicitation of February 26, 2026.

The Caribbean VA Healthcare System and Orlando VA Healthcare System intends to solicit and award an acquisition for Thyroid Cancer Molecular Test, as defined in the Statement of Work (SOW). This will be a Base of 12-months and Four (4) 12-month options. This requirement is solicited as Unrestricted.

The Primary North American Industry Classification System (NAICS) for this acquisition is 621511 Medical Laboratories, with a related small business size standard of $41.5 Million, and FSC/PSC is 6640. This solicitation is a Request for Quote (RFQ), for a Firm-Fixed Price (FFP) requirement contract, which will be advertised as unrestricted on or before 26 February 2026, via sam.gov website.

The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-06 10/01/2025. To be eligible for award, prospective offerors must be registered in the System for Award Management (SAM) Internet site, www.sam.gov. Amendments to the RFQ will be posted to this website only. It is the responsibility of the quoter to review the web page for notice of amendments, updates, or changes to the solicitation. No hard copies will be mailed.

The contractor must ensure that we receive the proposal on time; NO late proposals will be accepted/ considered. Any questions or concerns regarding this solicitation should be submitted no later than 03/02/2026 at 12:00 PM EST. No further questions will be accepted after that date and time. Please submit questions in writing via e-mail to the Contract Specialist, Yolanda Glover, at yolanda.glover@va.gov.

All quotations for this solicitation shall be submitted no later than 03/09/2026 at 4:00 PM EST. Please submit all responses to the Contract Specialist, Yolanda Glover, at yolanda.glover@va.gov Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(c). *Note* To prepare / complete a Quote, See Offerors Checklist under 52.212-2 Evaluation Commercial Items.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Interpace Diagnostics Corporation
UEI
F3JTMG615829
CAGE
5C4D8
Vendor location
Pittsburgh, PA
Contract
36C24826D0032
Obligated
$0.00, potential $1,524,000
Actions
1 between May 28, 2026 and May 28, 2026
Competition
Competed Under SAP, 3 offers received
Set-aside reported
No Set Aside Used.
Described as
Thyroid Cancer Test for Multi-Site for Orlando Vamc and San Juan Vamc
Match
award number 36C24826D0032 equals the contract number; same awarding office 36C248 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. February 26, 2026

    Solicitation, originally presolicitation

    FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement

    Due March 9, 2026 at 4:00 PM EDT. SAM.gov, notice 24adcb3278314b629c66797c99e21271

  2. February 26, 2026

    Presolicitation

    FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement

    SAM.gov, notice 35c856b47d254889b1b9b3082cf66769

  3. May 29, 2026

    Award notice

    Awarded to Interpace Diagnostics Corporation Pittsburgh 15222 for $1,524,000. SAM.gov, notice 7e9828ef58524ccfb3dd336771871c17

Points of contact

Also open from this buyer